Cargando…
AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor
Monoclonal gammopathies (MGs) are a wide range of diseases that may evolve or progress over time. Comorbidity plays a critical role in this setting. The co-occurrence of two MGs is not a rare event. The evidence on the association of systemic light chain (AL) amyloidosis and multiple myeloma (MM) is...
Autores principales: | Ríos-Tamayo, Rafael, Krsnik, Isabel, Gómez-Bueno, Manuel, Garcia-Pavia, Pablo, Segovia-Cubero, Javier, Huerta, Ana, Salas, Clara, Silvestre, Ramona Ángeles, Sánchez, Amelia, Manso, Marta, Delgado, Laura, Lahuerta, Juan José, Martínez-López, Joaquín, Duarte, Rafael F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382070/ https://www.ncbi.nlm.nih.gov/pubmed/37511893 http://dx.doi.org/10.3390/life13071518 |
Ejemplares similares
-
The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies
por: Hernández-Rivas, José-Ángel, et al.
Publicado: (2022) -
Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal
por: Ríos-Tamayo, Rafael, et al.
Publicado: (2022) -
Tumor Reduction in Multiple Myeloma: New Concepts for New Therapeutics
por: Alonso, Rafael, et al.
Publicado: (2022) -
Oligosecretory Myeloma With Amyloidosis and Alopecia
por: Bilal, Anum, et al.
Publicado: (2018) -
The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
por: Ríos-Tamayo, Rafael, et al.
Publicado: (2021)